Project 1 – Magnetoelectric Nanoparticles (MENPs) for Psychiatric and neurodegenerative Disorder Treatment

Our research explores the use of magnetoelectric nanoparticles (MENPs) as a groundbreaking, minimally invasive tool to modulate brain circuits involved in psychiatric disorders. By remotely activating MENPs with external magnetic fields, we aim to achieve precise, drug-free neuromodulation with high spatial specificity. This innovative approach has the potential to transform the treatment of conditions such as Alzheimer, Parkinson, and stress-related disorders.

Project 2 – Dopamine Transporter (DAT) Rat Models in Addiction and Stress-Related Disorders

We use genetically modified dopamine transporter (DAT) rat models to study how altered dopamine signaling shapes vulnerability to addiction and stress-related psychiatric conditions. These model allows us to identify molecular, behavioral, and neurobiological mechanisms underlying increased sensitivity to drugs and stress. Our goal is to uncover new therapeutic targets and biomarkers that can improve prevention and treatment strategies.